Home > PE Ratio > PARNAX LAB

PARNAX LAB
PE (Price/Earnings) Ratio

The Current P/E Ratio of PARNAX LAB is 10.79.

Share Price ₹108.3Jul 16,2025
Market Cap ₹124.5 Cr
Earnings-TTM₹11.5 CrTTM-Consolidated Results
Price/Earnings10.79xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for PARNAX LAB
Please provide your vote to see the results
PARNAX LAB is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of PARNAX LAB

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of PARNAX LAB is calculated as :

Current Market Cap [ ₹124.5 Cr] as on Jul 16,2025

(/) Earnings [ ₹11.5 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 10.79x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for PARNAX LAB , the investors are currently willing to pay 10.79 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PARNAX LAB !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of PARNAX LAB over the last five years.

Historical PE (Price/Earnings) ratio chart of PARNAX LAB


PE Ratio Performance Analysis for PARNAX LAB

- PARNAX LAB 's latest p/e ratio is 10.79x.

- PARNAX LAB 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 7.62x.

- PARNAX LAB 's operated at median p/e ratio of 6.94x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, PARNAX LAB 's p/e ratio peaked in Mar2022 at 15.68x.

- PARNAX LAB 's p/e ratio hit its five-year low in Mar2021 of 0x.


How does PARNAX LAB 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
PARNAX LAB 11.5410.79124.5
SUN PHARMACEUTICAL INDUSTRIES LTD10,980.1037.17408,091.0
DIVIS LABORATORIES LTD2,191.0082.75181,302.0
CIPLA LTD5,291.0522.50119,038.0
TORRENT PHARMACEUTICALS LTD1,911.0061.31117,170.0
DR REDDYS LABORATORIES LTD5,703.5018.42105,061.0
MANKIND PHARMA LTD2,003.2254.05108,281.0
ZYDUS LIFESCIENCES LTD4,614.8021.1297,463.8
LUPIN LTD3,306.2626.6688,134.8
AUROBINDO PHARMA LTD3,515.2619.0566,960.6
ABBOTT INDIA LTD1,414.4451.3572,628.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PARNAX LAB 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 10.79x
Max industry PE 82.75x
Median industry PE 26.66x
Average industry PE 36.83x



You may also like the below Video Courses